QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	94.38B
Revenue (ttm)	9.78B -2.8%
Net Income	-8.13B
EPS	-797.88
Shares Out	11.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,460
Open	8,210.00
Previous Close	8,210.00
Day's Range	8,040.00 - 8,700.00
52-Week Range	7,950.00 - 27,150.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2026

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490

Financial Performance

In 2025, QuadMedicine's revenue was 10.70 billion, an increase of 14.99% compared to the previous year's 9.30 billion. Losses were -6.93 billion, 39.5% more than in 2024.